<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03126396</url>
  </required_header>
  <id_info>
    <org_study_id>F-17-02-310 3166</org_study_id>
    <nct_id>NCT03126396</nct_id>
  </id_info>
  <brief_title>Assessment of Efficacy &amp; Tolerance of Urgo 310 3166 Dressing in Local Venous or Mixed Leg Ulcers</brief_title>
  <acronym>CASSIOPEE</acronym>
  <official_title>Assessment of Efficacy, Tolerance and Acceptability of Urgo 310 3166 Dressing in the Treatment of Local Venous or Mixed Leg Ulcers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Laboratoires URGO</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Laboratoires URGO</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Assessment of efficacy &amp; tolerance of Urgo 310 3166 dressing in the treatment of local venous
      or mixed leg ulcers.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Assessment of efficacy, tolerance and acceptability of Urgo 310 3166 dressing in the
      treatment of local venous or mixed leg ulcers: multicenter trial, conducted in France.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 11, 2017</start_date>
  <completion_date type="Actual">July 16, 2018</completion_date>
  <primary_completion_date type="Actual">May 22, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Efficacy - % of Wound Area Regression (WAR</measure>
    <time_frame>at week 12</time_frame>
    <description>% of Wound Area Regression (WAR), as a measure of efficacy</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">51</enrollment>
  <condition>Ulcers, Leg</condition>
  <arm_group>
    <arm_group_label>Urgo 310 3166 dressing</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Urgo 310 3166 dressing</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Urgo 310 3166 dressing</intervention_name>
    <description>Experimental: Urgo 310 3166 dressing</description>
    <arm_group_label>Urgo 310 3166 dressing</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Male or female over 18 years old who has provided his/her written informed consent

          2. Patient who can be monitored by the same investigation team throughout the whole
             duration of the study

          3. Patient who agrees to wear an effective venous compression system every day,
             associated with the trial dressing

          4. Leg ulcer with an Ankle Brachial Pressure Index (ABPI) not less than 0.7 and not more
             than 1.3

          5. Ulcer area between 3 and 20 cm2

          6. Ulcer duration between 3 and 18 months,

          7. Ulcer presenting a surface wound bed covered with 50% or more by granulation tissue

          8. Moderately or heavily exudative ulcers.

        Exclusion Criteria:

        A. Clinical infection on the wound bed.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>URGO</name>
      <address>
        <city>Chen√¥ve</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>December 2019</verification_date>
  <study_first_submitted>April 11, 2017</study_first_submitted>
  <study_first_submitted_qc>April 21, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 24, 2017</study_first_posted>
  <last_update_submitted>December 12, 2019</last_update_submitted>
  <last_update_submitted_qc>December 12, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">December 16, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Leg Ulcer</mesh_term>
    <mesh_term>Ulcer</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

